As of Jun 23
| +0.15 / +0.98%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 13.50, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a -12.62% decrease from the last price of 15.45.
The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.